Invention Grant
- Patent Title: LGR4 specific monoclonal antibodies and methods of their use
-
Application No.: US16062386Application Date: 2016-12-09
-
Publication No.: US10729781B2Publication Date: 2020-08-04
- Inventor: Qingyun Liu , Xing Gong , Kendra Carmon
- Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Applicant Address: US TX Austin
- Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- International Application: PCT/US2016/065788 WO 20161209
- International Announcement: WO2017/106034 WO 20170622
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K47/68 ; C07K16/28 ; C07K16/30 ; G01N33/50 ; G01N33/543 ; A61P35/00 ; A61K39/00
Abstract:
Isolated or recombinant anti-LGR4 monoclonal antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer.
Public/Granted literature
- US20180369403A1 LGR4 SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE Public/Granted day:2018-12-27
Information query
